New York Life Investment Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

New York Life Investment Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-331,728	Closed	-$11.9M	–	1460
2022 Q4	$11.9M	Buy	+331,728	New	+$8.29M	0.14%	165

New York Life Investment Management's IMGO Position: Q1 2023 in Review

New York Life Investment Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 331,728 shares — an estimated $11.9M sold.

New York Life Investment Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $11.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

New York Life Investment Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
New York Life Investment Management sold 331,728 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $11.9M.
New York Life Investment Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
New York Life Investment Management's Imago BioSciences, Inc. Common stock position peaked at $11.9M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on New York Life Investment Management's 13F filing for Q1 2023, filed 8 May 2023.